Odyssey Health (ODYY) R&D In Process (2021)
Odyssey Health has reported R&D In Process over the past 1 years, most recently at $9.4 million for Q2 2021.
- For Q2 2021, R&D In Process changed N/A year-over-year to $9.4 million; the TTM value through Jul 2021 reached $9.4 million, changed N/A, while the annual FY2021 figure was $9.4 million, N/A changed from the prior year.
- R&D In Process for Q2 2021 was $9.4 million at Odyssey Health.
- Over five years, R&D In Process peaked at $9.4 million in Q2 2021 and troughed at $9.4 million in Q2 2021.